Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares Ultra Semiconductors (USD) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

ProShares Ultra SemiconductorsTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

ProShares Ultra Semiconductors vs State Street SPDR S&P Biotech ETF — how do they compare? ProShares Ultra Semiconductors trades at $91.64, while State Street SPDR S&P Biotech ETF trades at $158.07. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, ProShares Ultra Semiconductors nearer its low. Which is the better fit depends on your goals.

USDXBI
Sector
Leveraged / InverseBroad Market / Factor
52-Week High
$113.53$164.28
52-Week Low
$40.97$86.92

Returns comparison

Trailing returns across standard periods

About ProShares Ultra Semiconductors

USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.

Read more on USD

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI